References

Diffuse large B-cell lymphoma

10.1056/nejmra2027612 · 2021 · External reference

Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment

10.1002/ajh.25460 · 2019 · External reference

CNS International Prognostic Index: a risk model for CNS relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP

10.1200/jco.2015.65.6520 · 2016 · External reference

Central nervous system prophylaxis in diffuse large B-cell lymphoma: a race to the bottom

10.3324/haematol.2020.266635 · 2021 · External reference

CNS prophylaxis for diffuse large B-cell lymphoma

10.1016/s1470-2045(22)00371-0 · 2022 · External reference

Central nervous system prophylaxis strategies in diffuse large B cell lymphoma

10.1007/s11864-018-0569-2 · 2018 · External reference

Advances in risk assessment and prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma

10.3324/haematol.2018.195834 · 2019 · External reference

CNS prophylaxis in DLBCL: time to say goodbye?

10.1182/blood.2021014043 · 2022 · External reference

Central nervous system prophylaxis in diffuse large B-cell lymphoma

10.1111/ejh.12763 · 2016 · External reference

Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma

10.1186/s40164-023-00467-2 · 2024 · External reference

Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy

10.1093/annonc/mdp432 · 2009 · External reference

Natural history of CNS relapse in patients with aggressive non-Hodgkin’s lymphoma: a 20-year follow-up analysis of SWOG 8516—Southwest Oncology Group

10.1200/jco.2008.16.8021 · 2009 · External reference

CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German high-grade non-hodgkin lymphoma study group (DSHNHL)

10.1182/blood-2008-10-182253 · 2009 · External reference

Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review

10.3324/haematol.2019.229948 · 2020 · External reference

Influence of rituximab on central nervous system relapse in diffuse large B-cell lymphoma and role of prophylaxis - A systematic review of prospective studies

10.1016/j.clml.2015.02.026 · 2015 · External reference

Ineffectiveness of high-dose methotrexate for prevention of CNS relapse in diffuse large B-cell lymphoma

10.1002/ajh.26181 · 2021 · External reference

Prevention and management of secondary central nervous system lymphoma

10.3324/haematol.2022.281457 · 2023 · External reference

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse

10.1038/s41408-021-00506-3 · 2021 · External reference

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

10.1182/blood.2021012888 · 2022 · External reference

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients

10.1182/blood.2021014506 · 2022 · External reference

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma

10.1038/bjc.2014.405 · 2014 · External reference

Outcomes of high-dose methotrexate for CNS prophylaxis in diffuse large B-cell lymphoma with an intermediate or high CNS-international prognostic index: a single-center retrospective cohort study

10.3892/mco.2022.2592 · 2022 · External reference

High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology

10.1182/blood-2004-05-1982 · 2005 · External reference